Can below-optimal vitamin D contribute to metabolic inflexibility?

Vitamin D has biologically credible links to glucose metabolism and inflammation, but its role in metabolic flexibility is indirect and not established as causal.

Clinical and metabolic evidence

• In 47 randomized trials of nondiabetic adults, vitamin D supplementation modestly reduced fasting insulin and HOMA-IR; meta-analyses in prediabetes and type 2 diabetes also reported HOMA-IR reductions. Effects were not uniform: a 26-week trial in vitamin-D-deficient prediabetes found no improvement in peripheral or hepatic insulin resistance measured by hyperinsulinemic-euglycemic clamp.
• Beta-cell effects are inconsistent. Some high-diabetes-risk cohorts showed improved IVGTT-derived disposition index and insulin secretion with cholecalciferol, but larger trial syntheses found no significant improvement in insulin secretion or beta-cell-function indices.
• In 48 overweight or obese older adults, higher 25(OH)D was associated with lower fasting respiratory quotient, greater post-glucose respiratory-quotient response, glucose oxidation, and insulin sensitivity—patterns consistent with better fuel switching. These are observational associations, however.

Inflammation and mechanisms

• Vitamin D may modestly reduce hs-CRP, especially with higher baseline inflammation; a VITAL substudy reported a transient 19% reduction at two years. Effects on overall CRP, IL-6, and TNF-α remain inconsistent.
• The proposed pathway is coherent: reduced insulin sensitivity can impair the normal shift from lipid oxidation while fasting toward glucose oxidation after carbohydrate exposure. Vitamin D supplementation reliably raises circulating 25(OH)D—by approximately 40 nmol/L across 47 randomized trials—but raising levels has not reliably improved clamp-measured insulin sensitivity, glucose oxidation, or substrate utilization.

Clinical implications

• A six-month double-blind trial in 62 vitamin-D-deficient adults with type 2 diabetes found no benefit of high-dose D3 for insulin sensitivity or substrate utilization.

Bottom line

• Below-optimal vitamin D may contribute indirectly to metabolic inflexibility in metabolically vulnerable individuals, but supplementation should correct deficiency rather than be expected to reliably restore insulin sensitivity, beta-cell performance, inflammatory control, or fuel flexibility.